FHU PRECISE retweeted
Replying to @LilleInfinite
La fédération hospitalo-universitaire PRECISE, organise une réunion d'information à destination des patients atteints de #maladiesinflammatoireschroniques le 14 octobre.
Inscription gratuite :
👋 Présentiel : urlz.fr/iJ6p
💻 Visioconférence : urlz.fr/iJ6m

ALT Programme : 9h CAFE D’ACCUEIL 9h15 INTRODUCTION - Pr David LAUNAY 9h30 - 10H30 Activité physique et bien-être - Pr Ingrid BANOVIC et Pr Claire TOURNY 10h - 10h30 Exemples d’activité physique adaptée - Pr Ingrid BANOVIC et Pr Claire TOURNY 10h30 - 11h Discussions, questions-réponses - Pr Ingrid BANOVIC et Pr Claire TOURNY PAUSE (15’) 11h15 - 12h Maladie inflammatoire chronique et nutrition - Pr Sébastien CZERNICHOW 12h - 12h30 Discussions, questions-réponses - Pr Sébastien CZERNICHOW 12h30 : Conclusion
FHU PRECISE retweeted
Our new study : B cells play a role in inflammatory fibrotic diseases : #scleroderma & #PAH as paradigms. Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertension frontiersin.org/articles/10.…
FHU PRECISE retweeted
A new study from our @LilleInfinite lab using @FhuPrecise and @contactfai2r CERAINO reference center database & biobanking : B cells are key actors in inflammation, fibrosis and vasculopathy : systemic sclerosis as a paradigm @RechercheUlille @CHU_Lille @InsermNordOuest
Our new study : B cells play a role in inflammatory fibrotic diseases : #scleroderma & #PAH as paradigms. Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertension frontiersin.org/articles/10.…
FHU PRECISE retweeted
Our new study! Dual-energy CT lung perfusion in #scleroderma pubmed.ncbi.nlm.nih.gov/3588… DECT lung perfusion provides complementary information to standard HRCT, depicting perfusion changes in SSc pts with normal/minimally infiltrated lung @CHU_Lille @RechercheUlille @UFR3S_ULille
FHU PRECISE retweeted
Proud to present our translational study just published in Frontiers in Endocrinology about the stimulatory effect of Tofacitinib on bone marrow adipocytes differentiation. @Julienpaccoujp7 @CHU_Lille
@medecine_Ulille @univ_lille @ULCO_Univ @BMA_Society
frontiersin.org/articles/10.…
FHU PRECISE retweeted
A new article from our @LilleInfinite team in nature.com @SciReports Simple gene signature to assess murine fibroblast polarization disq.us/t/4939x12 rdcu.be/cRp7f : a new insight in #inflammatory and #fibrosis models #scleroderma @RechercheUlille
FHU PRECISE retweeted
💥 New article from our group @LilleInfinite
Effects of IgG From Systemic Sclerosis Patients in Normal Dermal Fibroblasts: A Multi-Omics Study
Our first time doing multi-omics integrative analysis 🌸
@univ_lille @Inserm @CHU_Lille @Inria_Lille @InstUnivFr
frontiersin.org/article/10.3…
FHU PRECISE retweeted
Proud to present our letter just published in Joint Bone Spine about treatment persistence of tumour necrosis factors and IL-17 inhibitors in axial spondyloarthritis: a multi-center comparative analysis.
Special congrats to @ThibautDelpine (1st author) 😁
sciencedirect.com/science/ar…
FHU PRECISE retweeted
Bravo à Nathan qui publie dans @ms_MedSci (Paris) en Open Access une synthèse vu.fr/nPaf en français sur la #fibrose #pulmonaire #idiopathique.
@Inserm
@medecine_Ulille
@CHU_Lille
@UFR3S_ULille
FHU PRECISE retweeted
✨Our new review published in @FrontImmunol
Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis? 🤔🧐
Come & see terrific figures by our PhD students Aurélien and Louisa 🤩
@medecine_Ulille @univ_lille @Inserm @CHU_Lille @InstUnivFr
frontiersin.org/article/10.3…
FHU PRECISE retweeted
⏰ Il est encore temps de vous inscrire pour la 3° Soirée de discussion de cas présentés en #RCP FAI²R Mardi 7 juin 2022 à 19h 👉 Inscription gratuite sur : us06web.zoom.us/webinar/regi… Événement réservé aux pros 🩺 Programme : fai2r.org/actualites/soiree-… #maladiesrares #RCPFAI2R #fsmr
FHU PRECISE retweeted
Ruxolitinib is more effective than other JAK Inhibitors to treat VEXAS Syndrome: a retrospective multi center study. pubmed.ncbi.nlm.nih.gov/3560…











